Oncology and Hematology
Oncology and Hematology Clinical Practice
Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.
Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.
Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.
1-15 of 362

Safety Considerations and AE Monitoring for Trial Participation With Combination Regimens
MinuteCE®Safety Considerations and AE Monitoring for Trial Participation With Combination Regimens

The Pulmonology-Oncology Handoff: What Are the Potential Failure Points?
MinuteCE®The Pulmonology-Oncology Handoff: What Are the Potential Failure Points?

KRAS G12C Biology: Why Is This Mutation Different?
MinuteCE®KRAS G12C Biology: Why Is This Mutation Different?

Getting Trial-Ready: Matching Patients to Frontline Studies of KRAS G12C Inhibitors
MinuteCE®Getting Trial-Ready: Matching Patients to Frontline Studies of KRAS G12C Inhibitors
- advertisement

From Biopsy to Results: Building a Reflex-Ready Testing Workflow
MinuteCE®From Biopsy to Results: Building a Reflex-Ready Testing Workflow

Navigating the Evidence: Emerging Frontline Combination Strategies in KRAS G12C NSCLC
MinuteCE®Navigating the Evidence: Emerging Frontline Combination Strategies in KRAS G12C NSCLC

Beyond Steroids in Warm AIHA: A Practical Framework for Diagnosis, Relapse Management, and Emerging Therapies
CME/CEBeyond Steroids in Warm AIHA: A Practical Framework for Diagnosis, Relapse Management, and Emerging Therapies

What the Evidence Demands: A Clinician’s Decision Framework for LR-MDS Anemia Management
CME/CEWhat the Evidence Demands: A Clinician’s Decision Framework for LR-MDS Anemia Management

SOHO 2026 Debrief: Translating the Latest CLL Data Into Community Practice Decisions
CME/CESOHO 2026 Debrief: Translating the Latest CLL Data Into Community Practice Decisions

The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
CME/CEThe Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
- advertisement
CME/CE In-Person & Virtual EventSpotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
MinuteCE®Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders


































